Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1994-11-15
1997-08-05
Guzo, David
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
435 9141, 4351723, 4353201, 536 2372, A61K 3925, A61K 3929, C12N 1586
Patent
active
056539762
ABSTRACT:
The present invention provides a recombinant varicella-zoster virus prepared by inserting into the viral genome, nucleic acids from hepatitis B virus genome, a genomic DNA of the recombinant varicella-zoster virus, a live vaccine containing the recombinant varicella-zoster virus as an effective ingredient, an antigen derived from the recombinant varicella-zoster virus, and diagnostic agent containing the antigen. The recombinant varicella-zoster virus of the present invention can be utilized as a multivalent vaccine having an excellent immunity effect both on chickenpox and hepatitis B, and the expression products and genomic DNA thereof may be used as a multivalent diagnostic agent.
REFERENCES:
patent: 4963483 (1990-10-01), Ellis et al.
"Varicella-Zoster Virus as a Live Vector for the Expression of Foreign Ge, Lowe et al., PNAS, vol. 84, pp. 3896-3900, Jun. 1987.
Shiraki Kimiyasu
Takahashi Michiaki
Guzo David
The Research Foundation for Microbial Diseases of Osaka Universi
LandOfFree
Recombinant varicella-zoster virus and process for constructing does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant varicella-zoster virus and process for constructing , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant varicella-zoster virus and process for constructing will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1072869